Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2- and 6-pyridazinone substituents. [electronic resource] by
- Zhou, Yuefen
- Li, Lian-Sheng
- Dragovich, Peter S
- Murphy, Douglas E
- Tran, Chinh V
- Ruebsam, Frank
- Webber, Stephen E
- Shah, Amit M
- Tsan, Mei
- Averill, April
- Showalter, Richard E
- Patel, Rupal
- Han, Qing
- Zhao, Qiang
- Hermann, Thomas
- Kissinger, Charles R
- Lebrun, Laurie
- Sergeeva, Maria V
Producer: 20080512
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|